Backing UK Innovation with the £100M CIC Opportunity Fund 🚀 We’re pleased to launch the CIC Opportunity Fund, a £100 million growth fund anchored by @avivainvestors and @BPatientCap, with cornerstone commitments of £15 million and £20 million, respectively. This fund is designed to provide crucial scale-up financing for the UK’s deep tech and life sciences companies - helping them navigate the critical next stage of growth and remain competitive on a global stage. The UK is home to world-class research and breakthrough innovation, but too often, companies struggle to secure the funding needed to scale. With investments of up to £20 million per company, we aim to bridge this gap, ensuring that more IP-rich, high-impact businesses can grow and thrive in the UK. This investment also reflects the strong commitment of Aviva Investors and British Patient Capital to the UK’s innovation ecosystem. Their support strengthens Cambridge’s position as a world-leading science and technology hub and aligns with broader efforts to develop the Oxford-Cambridge Growth Corridor. We’re excited to partner with investors who share our vision and look forward to supporting the next generation of globally competitive technology companies. #CICOpportunityFund #VentureCapital #DeepTech #LifeSciences #Innovation #ScaleUp #Cambridge
